Cargando…

Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis

BACKGROUND: Using serum carbohydrate antigen 19–9 (CA 19–9) in discriminating between benign and malignant pancreatic disease remains controversial. We aim to evaluate the diagnostic value of serum CA 19–9 in predicting malignant pancreatic cystic lesions. METHODS: Eligible studies were identified t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shaobo, Hu, Ya, Gao, Xiang, Liao, Quan, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105948/ https://www.ncbi.nlm.nih.gov/pubmed/27835676 http://dx.doi.org/10.1371/journal.pone.0166406

Ejemplares similares

Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm
por: Cui, Ming, et al.
Publicado: (2023)

Pancreatic Cystic Neoplasms: Predictors of Malignant Behavior and Management
por: Atef, Ehab, et al.
Publicado: (2013)

Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report
por: Filipovic, Branka, et al.
Publicado: (2016)

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas
por: Qian, Yunzhen, et al.
Publicado: (2022)

Pancreatic Cystic Neoplasms
por: Limaiem, Faten, et al.
Publicado: (2014)

Cystic pancreatic neoplasms
por: Francis, Isaac R.
Publicado: (2015)

The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms
por: Wang, Huan, et al.
Publicado: (2022)

Biliary Mucinous Cystic Neoplasm of the Liver with Ovarian Stroma and Elevated Serum and Cystic Fluid Cancer Antigen 19-9 Levels
por: Fragulidis, Georgios P, et al.
Publicado: (2017)

Comparison of long-term benefits of organ-preserving pancreatectomy techniques for benign or low-grade malignant tumors at the pancreatic head
por: Li, Yatong, et al.
Publicado: (2017)

Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms
por: Liu, Jiang, et al.
Publicado: (2022)

Overweight Increases the Risk of Malignancy in Patients with Pancreatic Mucinous Cystic Neoplasms
por: Chang, Yu-Ting, et al.
Publicado: (2015)

Analysis of clinical characteristics and treatment of pancreatic cystic tumors
por: You, Lei, et al.
Publicado: (2016)

Malignant pancreatic serous cystic neoplasms: systematic review with a new case
por: Huh, Jimi, et al.
Publicado: (2016)

Prevalence of pancreatic cystic neoplasms on imaging exams: association with signs of malignancy risk
por: Falqueto, Aline, et al.
Publicado: (2018)

The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms
por: Zhou, Wentao, et al.
Publicado: (2017)

Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy
por: Alkharaan, Hassan, et al.
Publicado: (2020)

Diagnostic Concordance and Preoperative Risk Factors for Malignancy in Pancreatic Mucinous Cystic Neoplasms
por: Kim, Ga Hee, et al.
Publicado: (2022)

Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
por: Bertino, Gaetano, et al.
Publicado: (2013)

Pancreatic Cystic Neoplasms: Diagnosis and Management
por: Schubach, Abigail, et al.
Publicado: (2023)

Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies
por: Muniraj, Thiruvengadam, et al.
Publicado: (2021)

Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
por: Csiba, A., et al.
Publicado: (1984)

Malignancy risk factors and prognostic variables of pancreatic mucinous cystic neoplasms in Chinese patients
por: Xia, Qing, et al.
Publicado: (2023)

Huge Cystic Lymphangioma of the Pancreas Mimicking Pancreatic Cystic Neoplasm
por: Dalla Bona, Enrico, et al.
Publicado: (2012)

Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
por: Kang, Jae Seung, et al.
Publicado: (2021)

Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma
por: Gong, Yan, et al.
Publicado: (2023)

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
por: Deng, Shengming, et al.
Publicado: (2020)

Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study
por: Jiang, Dong, et al.
Publicado: (2022)

Pancreatic mucinous cystic neoplasm masquerading as pseudocyst
por: Kamboj, Amrit K., et al.
Publicado: (2017)

Pancreatic cystic neoplasms in real-time EUS
por: Kirtane, Tejas, et al.
Publicado: (2017)

Pancreatic cystic neoplasm diagnosis: Role of imaging
por: Sarno, Alessandro, et al.
Publicado: (2018)

Pancreatic cystic neoplasms in 2018: The final cut
por: Capurso, Gabriele, et al.
Publicado: (2018)

Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
por: Kim, Sunyoung, et al.
Publicado: (2020)

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022)

A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms
por: Lan, Chungen, et al.
Publicado: (2018)

Methylation changes at the GNAS imprinted locus in pancreatic cystic neoplasms are important for the diagnosis of malignant cysts
por: Faias, Sandra, et al.
Publicado: (2020)

Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
por: Wang, Xiuchao, et al.
Publicado: (2022)

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
por: Yue, Tingting, et al.
Publicado: (2011)

Acute Cholecystitis with Significantly Elevated Levels of Serum Carbohydrate Antigen 19-9
por: Akimoto, Shuji, et al.
Publicado: (2016)

MDCT evaluation of the growth kinetics of serous and benign mucinous cystic neoplasms of the pancreas
por: Chalian, Hamid, et al.
Publicado: (2011)

Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis
por: Benke, Márton, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vc8fsmr2s7f31mqcn3hud0e6va